| NCT ID | NCT07174245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Gestational Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-08-05 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of gestational diabetes during current pregnancy * age 18 or older * prescribed Dexcom G7 Exclusion Criteria: * Pregestational diabetes * known skin adhesive allergy which inhibits ongoing use of CGM * chronic oral steroid use.
Contact & Investigator
Grenye O'Malley, MD
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT07174245 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07174245 currently recruiting?
Yes, NCT07174245 is actively recruiting participants. Contact the research team at shaziah.hassan@mssm.edu for enrollment information.
Where is the NCT07174245 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07174245 clinical trial?
NCT07174245 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Grenye O'Malley, MD at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.